glaucoma

Documents about glaucoma

• Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension#28491ClinicalTrials.gov
• Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry#28492ClinicalTrials.gov
• Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops#121478ClinicalTrials.gov
• Glaucoma Assessment Via Reading Ability#121481ClinicalTrials.gov
• Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification#121485ClinicalTrials.gov
• Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade#121487ClinicalTrials.gov
• Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension#121495ClinicalTrials.gov
• 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination#121497ClinicalTrials.gov
• Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices#121500ClinicalTrials.gov
• Effect of Topical Dexmedetomidine on Intraocular Pressure#121512ClinicalTrials.gov
• Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients#123590ClinicalTrials.gov
• 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma#123614ClinicalTrials.gov
• Assessing Neurovisual Function in Patients With Cognitive Impairment#123616ClinicalTrials.gov
• Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)#123618ClinicalTrials.gov
• Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)#329389ClinicalTrials.gov
• Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma#329436ClinicalTrials.gov
• OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases#332679ClinicalTrials.gov
• Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients#332822ClinicalTrials.gov
• Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program#332845ClinicalTrials.gov
• Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma, Superior Versus Inferior#332847ClinicalTrials.gov
• Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial#332848ClinicalTrials.gov
• Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma#343737ClinicalTrials.gov
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension#346807ClinicalTrials.gov
• Use of Bevacizumab in Trabeculectomy Surgery#346808ClinicalTrials.gov
• Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone#346829ClinicalTrials.gov
• Post-operative Satisfaction With Glaucoma Surgery Trial#350037ClinicalTrials.gov
• Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension#353351ClinicalTrials.gov
• Study Comparing the Kinetics of Endothelial Cell Loss Associated With the XEN® Implant Versus Traditional Filtering Surgery for Glaucoma#363518ClinicalTrials.gov
• Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma#363525ClinicalTrials.gov

Related topics